Innovating Vaccines

ImmBio is developing next-generation vaccines targeting a number of serious infectious diseases, based on its proprietary technologies.

Find out more
About us

About us

ImmBio has an experienced team of scientists and executives based in state of the art facilities at the Babraham Research Campus, Cambridge UK. ImmBio develops innovative vaccines designed to establish broad immunity.

Find out more
Technology

Technology

Our vaccines protect by targeting antigens to immune system dendritic cells. This is achieved using two approaches, ImmBioVax™ our lead technology and ImmunoBodies™.

Find out more
Pipeline

Pipeline

Our pipeline includes vaccines against meningitis, tuberculosis and pneumococcal disease. ImmBio selects new vaccine targets where its technologies are most effective.

Find out more
Partner

Partner

ImmBio's strategy is to develop innovative vaccines in partnership with leading centres of expertise and to out-license late-stage development and commercialisation. Please contact ImmBio to find out more.

Find out more